Table 3.
Survey section 2: COVID-19 preventive measures.
| Survey questions | Answers | All, n (%) n = 122 | Red Zoneb, n (%) n = 39 (32) | North, n (%) n = 26 (21) | Centre, n (%) n = 18 (15) | South and islands, n (%) n = 25 (20) |
|---|---|---|---|---|---|---|
| Triage processd for pts accessing oncologic services | No | 6 (5) | 2 (5) | 1 (4) | 1 (6) | 2 (4) |
| Yes | 112 (95) | 37 (95) | 25 (96) | 17 (94) | 23 (96) | |
| Which kind of pts are triageda | All | 79 (70) | 24 (61) | 24 (92) | 10 (56) | 14 (56) |
| Pts with fever | 20 (19) | 7 (18) | 1 (4) | 5 (28) | 6 (24) | |
| Pts with RSe | 14 (12) | 5 (13) | 1 (4) | 4 (22) | 4 (16) | |
| Pts with feverf + RS | 8 (7) | 8 (20) | 0 | 4 (22) | 5 (20) | |
| Pts are questioned about feverf, RS and/or contact with high-risk subjects | No | 5 (4) | 1 (2) | 1 (4) | 2 (11) | 1 (4) |
| Yes | 113 (96) | 38 (97) | 25 (96) | 16 (89) | 24 (96) | |
| Diagnostic work-up for pts with suspicious symptoms | No | 39 (33) | 9 (23) | 6 (23) | 9 (50) | 13 (52) |
| Yes | 79 (67) | 30 (77) | 20 (77) | 9 (50) | 12 (48) | |
| Measures for reducing pts accesses from first cases of COVID-19 | No | 11 (9) | 5 (13) | 2 (8) | 1 (6) | 1 (4) |
| Yes | 107 (91) | 34 (87) | 24 (92) | 17 (94) | 24 (96) | |
| Which kind of pts are these measures addressed toa | All follow-up visits (non-urgent) | 98 (92) | 30 (77) | 24 (92) | 15 (83) | 22 (88) |
| Follow-up visits of high-risk ptsc | 33 (31) | 9 (23) | 7 (27) | 7 (39) | 6 (25) | |
| pts receiving adjuvant therapy | 4 (4) | 0 | 1 (4) | 1 (6) | 2 (8) | |
| Alternative modalities to get in touch with pts (e.g. telephonic interview) | No | 23 (20) | 10 (26) | 3 (11) | 4 (22) | 4 (16) |
| Yes | 88 (80) | 25 (64) | 21 (81) | 14 (78) | 22 (88) | |
| Reduced access for pts coming from Red Zone, and/or reporting feverf and/or RS | No | 21 (18) | 9 (23) | 3 (11) | 6 (33) | 2 (8) |
| No, Red Zone out of catchment area | 18 (15) | 2 (5) | 4 (15) | 4 (22) | 6 (24) | |
| Yes | 77 (66) | 28 (72) | 19 (73) | 8 (45) | 17 (68) | |
| Reduced access for visitors and/or caregivers of pts in hospital ward, day hospital, outpatient visits | No | 0 | 1 (3) | 0 | 0 | 0 |
| Yes, limited access for one visitor per patient | 59 (51) | 23 (59) | 10 (38) | 9 (50) | 14 (56) | |
| Yes, denied access for visitors | 50 (43) | 13 (33) | 15 (58) | 9 (50) | 11 (44) | |
| Autonomous management of measures | Yes | 50 (43) | 17 (44) | 11 (42) | 7 (39) | 12 (48) |
| Medical direction measures | 53 (46) | 18 (46) | 13 (50) | 6 (33) | 12 (48) | |
| Regional measures | 13 (11) | 4 (10) | 2 (8) | 5 (28) | 1 (4) | |
| Measures for reducing pts accesses in view of actual legislationga | No, internal measures already activated | 61 (52) | 22 (56) | 12 (46) | 9 (50) | 16 (64) |
| Yes | 59 (51) | 19 (49) | 16 (61) | 9 (50) | 9 (36) | |
| Which kind of pts are these measures addressed toa | All follow-up visits (non-urgent) | 82 (92) | 26 (67) | 21 (81) | 12 (67) | 19 (76) |
| Follow-up visits of high-risk ptsb | 26 (29) | 9 (23) | 4 (15) | 3 (23) | 8 (32) | |
| Pts receiving adjuvant therapy | 3 (3) | 0 | 1 (4) | 1 (8) | 2 (8) | |
| Did your Country provide guidelines for oncologic pts management during COVID-19 emergency? | No | 33 (28) | 11 (28) | 7 (27) | 6 (33) | 7 (28) |
| Yes | 73 (63) | 26 (67) | 17 (65) | 8 (45) | 16 (64) | |
| Only for hospital pts | 10 (9) | 2 (5) | 2 (8) | 4 (22) | 2 (8) | |
| How is your activity changing in view of actual legislationg? | Significant decreased | 28 (24) | 9 (23) | 6 (23) | 7 (39) | 5 (20) |
| Negligible decreased | 70 (60) | 23 (59) | 18 (69) | 9 (50) | 15 (60) | |
| Unchanged | 10 (9) | 5 (13) | 1 (4) | 1 (6) | 2 (8) | |
| Increased | 0 | 0 | 0 | 0 | 0 | |
| UNK | 8 (7) | 2 (5) | 1 (4) | 1 (6) | 3 (12) |
BMI, body mass index; pts, patients; RS, respiratory symptom; UNK, unknown; COVID-19, novel coronavirus disease.
a
Questions with more than one possible answer.
b
Red Zone at the time of the survey includes the following Italian countries: Lombardia, Emilia Romagna and Veneto.
c
Age ≥75 years, cardiovascular and/or respiratory disease, chronic infections, diabetes, obesity (BMI ≥ 30), immune-suppressive therapies.
d
Patients triage includes: vital signs, and respiratory signs/symptoms evaluation.
e
Definition of fever: TC ≥ 37.5 °C.
f
Definition of respiratory symptoms: dyspnea, cough, rhinitis.
g
Administrative order issued on 11th March (refer text for complete details).